Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q99943

Entry ID Method Resolution Chain Position Source
AF-Q99943-F1 Predicted AlphaFoldDB

130 variants for Q99943

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 2 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 3 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA136906249
rs529759736
5 P>S No 1000Genomes
TOPMed
gnomAD
ClinGen
rs1171950859
CA363498997
7 A>V No gnomAD
ClinGen
CA363498967
rs1445530362
9 M>L No TOPMed
ClinGen
rs759269879
CA363497975
11 L>V No ExAC
TOPMed
gnomAD
ClinGen
CA136906234
rs977923338
14 L>P No gnomAD
ClinGen
rs1487514646
CA363497872
17 L>P No gnomAD
ClinGen
CA3737638
rs760144285
24 T>I No ExAC
TOPMed
gnomAD
ClinGen
rs1277567457
CA363497682
28 C>S No TOPMed
gnomAD
ClinGen
rs1277567457
CA363497685
28 C>Y No TOPMed
gnomAD
ClinGen
CA3737635
rs11964847
VAR_050593
30 P>S No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
UniProt
dbSNP
rs769152569
CA3737633
31 S>G No ExAC
gnomAD
ClinGen
rs769152569
CA3737634
31 S>R No ExAC
gnomAD
ClinGen
CA3737632
rs749653275
37 K>Q No ExAC
ClinGen
rs1348935316
CA363497596
38 M>V No ClinGen
TOPMed
rs756914433
CA136906175
39 A>G No TOPMed
gnomAD
ClinGen
rs780487704
CA3737631
47 F>L No ExAC
TOPMed
gnomAD
ClinGen
rs1373851668
CA363497516
49 A>D No TOPMed
ClinGen
rs1170608309
CA363497510
50 V>A No gnomAD
ClinGen
CA363497501
rs1279346407
52 A>T No ClinGen
TOPMed
CA3737629
rs750516488
53 I>V No ExAC
gnomAD
ClinGen
TCGA novel 57 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3737628
rs547166818
58 V>M No 1000Genomes
ExAC
gnomAD
ClinGen
rs1423578165
CA363497456
59 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA3737626
rs200978599
63 V>I No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
COSM252329
CA3737625
rs765147808
64 E>K ovary Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
cosmic curated
NCI-TCGA
rs1457777869
CA363497357
71 L>V No gnomAD
ClinGen
CA3737618
rs767062379
76 I>V No ExAC
TOPMed
gnomAD
ClinGen
rs769277436
CA3737615
81 G>E No ClinGen
ExAC
gnomAD
CA3737616
rs775051881
81 G>R No ExAC
TOPMed
gnomAD
ClinGen
CA3737614
rs752064887
83 R>Q No ExAC
TOPMed
gnomAD
ClinGen
CA363497151
rs1375159178
85 E>D No TOPMed
ClinGen
rs1330006904
CA363497157
85 E>G No TOPMed
ClinGen
rs1354009194
CA363497043
91 H>L No TOPMed
gnomAD
ClinGen
rs867888606
CA136906077
93 P>H No gnomAD
ClinGen
rs867888606
CA363496997
93 P>L No gnomAD
ClinGen
CA363496969
rs1352581755
94 P>R No gnomAD
ClinGen
rs1240461196
CA363496984
94 P>S No ClinGen
gnomAD
CA3737613
rs775971995
95 S>L No ExAC
gnomAD
ClinGen
CA3737610
rs781203974
96 Q>E No ExAC
gnomAD
ClinGen
CA363496907
rs1386652159
97 P>S No gnomAD
ClinGen
CA3737608
rs747055100
98 Y>C No ExAC
gnomAD
ClinGen
rs1039133406
CA136906054
107 S>C No Ensembl
ClinGen
TCGA novel 113 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs900277951
CA136905923
114 M>I No gnomAD
ClinGen
CA363496183
rs1340318719
120 R>P No gnomAD
ClinGen
rs1276655020
CA363496111
124 I>L No gnomAD
ClinGen
TCGA novel 127 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 132 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1333740041
CA363495826
133 G>A No gnomAD
ClinGen
rs1398644029
CA363495686
138 A>V No gnomAD
ClinGen
rs1464996408
CA363495606
142 A>T No ClinGen
gnomAD
CA3737580
rs371326067
143 G>E No ESP
ExAC
gnomAD
ClinGen
rs1164341942
CA363495480
148 D>N No TOPMed
ClinGen
rs1472994637
CA363495433
149 R>Q No ClinGen
gnomAD
TCGA novel 149 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363495363
rs1236603443
151 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA363495361
rs1184868508
151 R>H No ClinGen
gnomAD
rs763726315
CA363495336
152 T>K No ExAC
TOPMed
ClinGen
CA3737578
rs763726315
152 T>M No ClinGen
ExAC
TOPMed
CA136905884
rs753269798
153 G>E No ExAC
TOPMed
gnomAD
ClinGen
rs753269798
CA3737576
153 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA136905883
rs995632838
154 D>N No TOPMed
ClinGen
rs765658820
CA3737575
157 S>N No ExAC
gnomAD
ClinGen
rs1561845816
CA363495269
157 S>R No ClinGen
Ensembl
TCGA novel 160 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363495193
rs1042001103
161 E>K No TOPMed
ClinGen
CA136905880
rs1042001103
161 E>Q No TOPMed
ClinGen
CA363495156
rs1256689246
163 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
rs962400353
CA136905863
169 Q>* No ClinGen
TOPMed
CA3737560
rs777508622
CA3737561
171 V>L No ExAC
TOPMed
gnomAD
ClinGen
rs1225793014
CA363494882
173 V>F No TOPMed
ClinGen
TCGA novel 174 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363494841
rs1226857091
175 V>M No gnomAD
ClinGen
rs1356176472
CA363494797
177 P>S No ClinGen
gnomAD
rs752223345
CA3737558
183 H>R No ExAC
gnomAD
ClinGen
rs765822175
CA3737557
184 N>K No ExAC
gnomAD
ClinGen
CA363494646
rs1295228923
184 N>S No TOPMed
gnomAD
ClinGen
TCGA novel 187 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 189 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363494478
rs1349120316
192 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA3737555
rs754331804
195 F>L No ExAC
gnomAD
ClinGen
CA3737554
rs766659199
199 V>M No ExAC
TOPMed
gnomAD
ClinGen
rs1437282081
CA363494351
200 Q>K No gnomAD
ClinGen
rs760974670
CA3737553
201 A>S No ExAC
gnomAD
ClinGen
CA3737552
rs778847928
202 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA363494310
rs1346669885
202 Q>R No Ensembl
ClinGen
CA3737534
rs767772319
205 I>V No ExAC
gnomAD
ClinGen
CA3737529
rs776489092
210 M>I No ExAC
gnomAD
ClinGen
CA3737530
rs763029554
210 M>L No ExAC
gnomAD
ClinGen
rs147585779
CA3737527
220 K>R No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA3737526
rs773164497
222 R>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 223 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1174931612
CA363493574
223 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA3737525
rs771955233
224 F>L No ExAC
gnomAD
ClinGen
CA136905666
rs149893502
225 T>N No ESP
ClinGen
rs747761876 226 S>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs975811201
CA136905479
232 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No TOPMed
gnomAD
ClinGen
NCI-TCGA
rs1180646502
CA363493078
232 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA363491110
rs1237568347
238 P>S No gnomAD
ClinGen
COSM1443578
rs1193939291
CA363491017
239 T>M Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No gnomAD
ClinGen
cosmic curated
NCI-TCGA
CA136905453
rs867669239
247 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No Ensembl
ClinGen
NCI-TCGA
TCGA novel 248 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363490664
rs1310981457
252 D>H No gnomAD
ClinGen
CA363490552
rs1331273987
255 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA363490557
rs1375429510
255 R>W No gnomAD
ClinGen
CA363490365
rs1582655409
260 T>A No Ensembl
ClinGen
rs760726399
CA3737509
261 V>L No ExAC
gnomAD
ClinGen
CA363490281
rs139093368
263 R>G No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs987013114
CA136905441
263 R>Q No TOPMed
gnomAD
ClinGen
rs139093368
CA3737508
263 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
rs967530858
CA136905435
265 I>V No TOPMed
ClinGen
CA3737507
rs747965391
267 T>I No ExAC
gnomAD
ClinGen
rs747965391
CA3737506
267 T>N No ClinGen
ExAC
gnomAD
rs1246780410
CA363490078
269 G>D No TOPMed
ClinGen
rs773946115
CA363490069
270 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs748794275
CA3737503
270 R>P No ExAC
TOPMed
gnomAD
ClinGen
rs748794275
CA3737504
270 R>Q No ExAC
TOPMed
gnomAD
ClinGen
rs773946115
CA363490059
270 R>W No ExAC
TOPMed
gnomAD
ClinGen
rs779566214
CA3737502
271 G>S No ExAC
gnomAD
ClinGen
CA136905408
rs957776755
273 G>D No Ensembl
ClinGen
rs1002261447
CA136905388
274 D>G No TOPMed
ClinGen
CA3737501
rs769257329
274 D>N No ExAC
gnomAD
ClinGen
CA3737500
rs746381833
278 K>N No ExAC
TOPMed
gnomAD
ClinGen
rs757621954
CA3737498
279 P>L No ExAC
TOPMed
gnomAD
ClinGen
rs781622314
CA3737499
279 P>T No ExAC
gnomAD
ClinGen
TCGA novel 281 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777896622
CA3737496
282 G>S No ExAC
TOPMed
gnomAD
ClinGen
CA3737495
rs375715875
284 G>R No ESP
ExAC
TOPMed
ClinGen

No associated diseases with Q99943

2 regional properties for Q99943

Type Name Position InterPro Accession
conserved_site Aminoacyl-tRNA synthetase, class I, conserved site 42 - 52 IPR001412
domain RNA-binding S4 domain 336 - 374 IPR002942

Functions

Description
EC Number 2.3.1.51 Transferring groups other than amino-acyl groups
Subcellular Localization
  • Endoplasmic reticulum membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

1 GO annotations of molecular function

Name Definition
1-acylglycerol-3-phosphate O-acyltransferase activity Catalysis of the reaction: acyl-CoA + 1-acyl-sn-glycerol-3-phosphate = CoA + 1,2-diacyl-sn-glycerol-3-phosphate.

5 GO annotations of biological process

Name Definition
CDP-diacylglycerol biosynthetic process The chemical reactions and pathways resulting in the formation of CDP-diacylglycerol, CDP-1,2-diacylglycerol, a substance composed of diacylglycerol in glycosidic linkage with cytidine diphosphate.
phosphatidic acid biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
phospholipid metabolic process The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
positive regulation of cytokine production Any process that activates or increases the frequency, rate or extent of production of a cytokine.
positive regulation of cytokine-mediated signaling pathway Any process that activates or increases the frequency, rate or extent of a cytokine mediated signaling pathway.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P33333 SLC1 1-acyl-sn-glycerol-3-phosphate acyltransferase Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q95JH2 AGPAT1 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha Bos taurus (Bovine) PR
O15120 AGPAT2 1-acyl-sn-glycerol-3-phosphate acyltransferase beta Homo sapiens (Human) PR
Q8K3K7 Agpat2 1-acyl-sn-glycerol-3-phosphate acyltransferase beta Mus musculus (Mouse) PR
Q9LLY4 BAT2 1-acyl-sn-glycerol-3-phosphate acyltransferase BAT2, chloroplastic Brassica napus (Rape) PR
Q8GXU8 LPAT1 1-acyl-sn-glycerol-3-phosphate acyltransferase LPAT1, chloroplastic Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MDLWPGAWML LLLLFLLLLF LLPTLWFCSP SAKYFFKMAF YNGWILFLAV LAIPVCAVRG
70 80 90 100 110 120
RNVENMKILR LMLLHIKYLY GIRVEVRGAH HFPPSQPYVV VSNHQSSLDL LGMMEVLPGR
130 140 150 160 170 180
CVPIAKRELL WAGSAGLACW LAGVIFIDRK RTGDAISVMS EVAQTLLTQD VRVWVFPEGT
190 200 210 220 230 240
RNHNGSMLPF KRGAFHLAVQ AQVPIVPIVM SSYQDFYCKK ERRFTSGQCQ VRVLPPVPTE
250 260 270 280
GLTPDDVPAL ADRVRHSMLT VFREISTDGR GGGDYLKKPG GGG